Hamiya Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 50.00 K
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2020
- Revenue Growth -73.92%
- Profit Growth -1080.02%
- Ebitda -654.28%
- Net Worth -41.12%
- Total Assets -40.13%
About Hamiya Life Sciences
Hamiya Life Sciences Private Limited (HLSPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 17 December 2018 (Six years and one month 15 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 50.00 K , as per Ministry of Corporate Affairs (MCA) records.
Anvar Sait and Stalin Illuri serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999TG2018PTC129072
-
Company No.
129072
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Dec 2018
-
Date of AGM
31 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Hamiya Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anvar Sait
|
Managing Director | 17-Dec-2018 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Stalin Illuri
|
Director | 17-Dec-2018 | Current |
Financial Performance of Hamiya Life Sciences.
Hamiya Life Sciences Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 73.92% decrease. The company also saw a substantial fall in profitability, with a 1080.02% decrease in profit. The company's net worth observed a substantial decline by a decrease of 41.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hamiya Life Sciences?
Unlock access to Hamiya Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Hamiya Solutions Private LimitedAnvar Sait is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hamiya Life Sciences?
Unlock and access historical data on people associated with Hamiya Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hamiya Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hamiya Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.